Indian Pharmaceutical Supplier to Jordan.
Jordan punches above its weight in MENA pharmaceutical terms: a mature domestic generics industry, a credible Jordan Food and Drug Administration (JFDA), and King Hussein Cancer Center (KHCC) as one of the region's most significant oncology referral centres. The country is a pharma-forward middle-income market with meaningful recognition weight into Iraq, Yemen, Libya, Sudan and the broader Levant, which makes it one of the better strategic first-filing markets for an Indian supplier targeting the non-GCC Arab market. Public and specialist demand runs through KHCC, Jordan University Hospital, Prince Hamza Hospital, Al-Bashir Hospital and the Royal Medical Services network; private-sector demand sits with Istiklal Hospital, Al-Khalidi Hospital, Jordan Hospital, Specialty Hospital and Ibn Al Haytham Hospital. Products enter through Queen Alia International Airport (AMM) and Aqaba Port. Our Mumbai regulatory desk files directly with JFDA; our Dubai commercial desk handles day-to-day MENA coordination.
JFDA: disciplined, experienced, generics-literate.
The Jordan Food and Drug Administration is an autonomous regulatory authority operating under the Ministry of Health framework, with combined responsibility for pharmaceutical registration, GMP inspection, pharmacovigilance and pricing oversight. JFDA reviewers have decades of experience with the country's large domestic generics industry and with cross-border Indian CTD submissions, which in practical terms means a more experienced front-door for well-prepared Indian WHO-GMP dossiers than most MENA regulators offer.
Timelines land at 10 to 16 months for a WHO-GMP-sourced generic with a clean dossier, API DMF and stability covering six months accelerated plus twelve months real-time. Fast-track and essential-medicines priority schemes are available for specific shortage-risk categories. Biologics, biosimilars and new chemical entities run 18 to 30 months. Pack-size and artwork variations clear in three to six months.
JFDA accepts ICH CTD submissions with Jordan-specific Module 1: Arabic SmPC and PIL, CoPP on WHO format, GMP certificate, site master file summary and pricing documentation. Pricing is benchmarked to a defined reference-country basket with public-sector tender pricing visible through Joint Procurement Department (JPD) awards and Ministry of Health historical data. JFDA and the pricing committee move together more coherently than many regional regulators, which reduces the common problem of earning a marketing authorisation without earning a workable commercial price.
Arabic labelling is mandatory: bilingual outer carton and Arabic PIL for retail and OTC, with JFDA artwork review and approval before print. Controlled substances run under JFDA narcotic-control permits aligned to INCB quotas, and the Jordanian importer of record must hold a current narcotic licence. Pharmaceutical imports through Jordan's free zones for re-export are a common model and we coordinate FZ structuring through our Dubai commercial desk.
Call & WhatsApp the Mumbai desk: +91 70156 05768 · info@mcareexports.com · Mon–Sat 09:30–18:30 IST
Six capabilities, shaped around a pharma-forward middle-income market.
JFDA dossier preparation and filing
ICH CTD dossiers with Jordan-specific Module 1, Arabic SmPC and PIL, CoPP on WHO format, GMP certificate, pricing documentation referenced to JPD awards and the JFDA reference basket. Variations and renewals tracked on a shared calendar with the Jordanian importer of record.
MoH and JPD tender response
Technical and commercial pack tuned to Ministry of Health and Joint Procurement Department tender formats: JFDA registration, CoA, CoO, GMP, PSUR, stability, Arabic artwork and a price schedule aligned to JPD award history and JFDA reference pricing.
KHCC oncology supply
Contract supply to King Hussein Cancer Center covering therapeutic oncology (trastuzumab, rituximab, bevacizumab, pertuzumab biosimilars; capecitabine; kinase inhibitors), supportive care (pegfilgrastim, granisetron, ondansetron) and critical-care injectables. KHCC is the anchor regional oncology buyer for Jordan and referred patients from adjacent markets.
Private hospital network supply
Contract supply to Istiklal, Al-Khalidi, Jordan Hospital, Specialty Hospital and Ibn Al Haytham. Batch-level traceability, CoA and CoO on every dispatch, QP release letter where the pharmacovigilance function requires it.
Arabic bilingual artwork
JFDA-compliant Arabic typesetting with native-speaker medical review, outer-carton bilingual layout, PIL translation and artwork proof secured with JFDA before any print run commits. Levantine-Arabic conventions distinct from Gulf or Egyptian artwork.
Levant regional launch strategy
Where the commercial plan targets Iraq, Yemen, Libya, Sudan or Palestine alongside Jordan, we design the JFDA dossier as an anchor reference for downstream filings, capturing recognition credit where each target regulator accepts it.
Mumbai to Queen Alia via the Gulf, Aqaba for volume.
Air freight: BOM-AMM routes via Dubai (Emirates), Doha (Qatar Airways) or Abu Dhabi (Etihad), with block times of seven to nine hours including transfer. Royal Jordanian operates direct rotations out of DEL and select BOM windows. Door-to-door for ambient pharmaceutical cargo clears in three to five working days; JFDA import clearance at AMM is handled through the national single-window customs platform, and our nominated freight agent resolves landing-side queries.
Sea freight: Nhava Sheva to Aqaba Port runs a twelve-to-sixteen-day transit, with weekly feeder sailings from MSC, CMA CGM, ONE and Hapag-Lloyd, typically trans-shipped through Jeddah or Jebel Ali. Aqaba is Jordan's sole maritime outlet; road haulage from Aqaba to Amman runs about four hours via the Desert Highway. Aqaba Special Economic Zone (ASEZA) free-zone structuring is available for re-export-oriented flows. Less-than-container-load consolidation is available for orders below 10 CBM.
Cold-chain: Envirotainer RAP e2 and RKN e1 for 2-8 degrees active, va-Q-tec passive for 15-25 ambient, and continuous temperature logging on every consignment with invoice value above USD 15,000. Queen Alia's cool-dolly capacity through the Gulf-hub carriers is robust; Dubai or Doha positioning is used as a 24-to-48-hour fallback where direct AMM slots are tight. Insurance on Institute Cargo Clauses A, door-to-door.
Payment terms: TT 30% advance and 70% against scanned Bill of Lading for first-time customers, or sight LC through Arab Bank, Housing Bank for Trade and Finance, Jordan Kuwait Bank or HSBC Jordan. Repeat customers move to open account at 60 to 90 days after five clean shipments, subject to credit-insurer cover. Atradius and Euler Hermes cover on larger accounts.
What KHCC, MoH tenders and the private network actually order.
Oncology is the marquee Jordanian category. KHCC runs one of the most sophisticated oncology operations in the MENA region and is a major institutional buyer for therapeutic biosimilars (trastuzumab, rituximab, bevacizumab, pertuzumab), targeted small molecules (capecitabine, TKIs, CDK4/6 inhibitors where regional pricing allows), supportive care (pegfilgrastim, granisetron, ondansetron, palonosetron, aprepitant) and palliative-care supply. Jordan's oncology patient mix includes significant referred-in volume from Iraq, Palestine and the broader Levant, which compounds KHCC's formulary demand above what domestic demographics alone would generate.
Cardiometabolic and critical-care round out the volume profile: statins, SGLT2 inhibitors, DPP-4 inhibitors, ARBs, beta-blockers, long-acting insulin analogues, noradrenaline, vasopressin, propofol and the standard critical-care injectable suite. Antibiotics, maternal-health injectables, ophthalmology and dermatology lines cover the general-hospital formulary. The private-hospital network weights more heavily toward branded and high-specification formulations than the public sector.
Every line ships with JFDA-compliant bilingual labelling, pricing-committee-compliant commercial schedules and CoA-per-batch documentation.
A Gulf-based sponsor used M Care in 2024 to run a Jordan-anchored Levant launch on a three-SKU oncology biosimilar portfolio, with KHCC as the lead institutional buyer. We filed JFDA dossiers eight weeks after brief, cleared queries in two cycles and secured marketing authorisations across a 13-to-15-month window. KHCC onboarding ran in parallel with the second half of JFDA review; the first commercial shipment landed through Queen Alia on a Qatar Airways cargo slot 14 days after the final MA. The JFDA dossiers then served as recognition anchors for parallel filings into Iraq and Palestine, which the sponsor estimates compressed the onward timelines by five to seven months each.
Why Indian pharma, why M Care, and what a Jordanian buyer actually receives.
Jordan is one of the more rewarding MENA markets for an Indian supplier that takes documentation seriously. JFDA's reviewer base is experienced, its pricing decisions are coherent with its regulatory decisions, and KHCC's institutional demand gives specialist oncology lines a real home the moment a dossier clears. Indian manufacturing fits this shape well: WHO-GMP capacity covers roughly a fifth of global generic finished-dosage-form volume, API unit economics sit comfortably inside the JFDA reference-basket envelope, and ICH-aligned dossiers move through JFDA's review at competitive pace.
The question most Jordanian buyers and their sponsors ask is how to design the JFDA filing so that it does double duty as an anchor reference for onward Levant and North Africa submissions without compromising the Jordanian commercial shape. M Care's Mumbai head office handles the regulatory and CMC engine: dossier writing, stability coordination, pharmacovigilance and CoPP procurement, with Levant-reuse design baked into the submission. Our Dubai commercial desk manages the Jordanian importer-of-record relationship, KHCC and MoH tender timing, price-committee strategy and the onward Iraq, Palestine and Libya follow-on filings. Treating Jordan as a Levant anchor rather than a standalone filing is the single biggest lever a sponsor has over the regional timeline.
Three specifics make the relationship different. First, a single named account manager who owns the file from the first JFDA submission through the KHCC onboarding, the MoH or JPD tender response, and the onward Iraq, Palestine or Libya filings. Second, realistic pricing posture: we anchor commercial schedules to JPD award history and JFDA reference prices rather than aspirational comparators, which keeps the price-committee decision clean. Third, honest timelines. We say 10 to 16 months for a JFDA generic because that is what clean submissions actually run, and we do not over-claim fast-track unless the molecule has a genuine essential-medicines or shortage priority.
One practical note for first-time Jordanian buyers: JPD tender dynamics favour established relationships and consistent delivery records, and a new-entrant bid without a credible in-market reference will often lose on the non-price evaluation components even when the price is competitive. We address this by building the initial Jordanian commercial profile around KHCC and the private-hospital network for the first twelve months, then bringing JPD tender entry into the plan once reference shipments are visible in-market.
Jordan pharmaceutical import: common questions.
Which authority registers pharmaceutical products in Jordan?
The Jordan Food and Drug Administration (JFDA), an autonomous regulator under the Ministry of Health framework, with combined responsibility for pharmaceutical registration, GMP inspection, pharmacovigilance and pricing oversight.
How long does JFDA registration typically take?
Ten to sixteen months for a WHO-GMP-sourced generic with a clean dossier. Fast-track and essential-medicines priority tracks are available for specific shortage-risk categories. Biologics and complex generics run 18 to 30 months.
Is Arabic labelling mandatory in Jordan?
Yes. Bilingual Arabic and English outer carton, Arabic PIL for retail and OTC lines, with JFDA artwork approval before any print run. Levantine-Arabic conventions distinct from Gulf or Egyptian artwork.
How is JFDA pricing determined?
JFDA's pricing committee benchmarks each new registration against a defined reference-country basket and applies therapeutic-comparator rules. Pricing decisions move coherently with the regulatory decision, which reduces the common problem of earning a marketing authorisation without a workable commercial price.
Can Jordan act as a reference market for other Arab markets?
Yes. JFDA registrations carry recognition weight into Iraq, Yemen, Libya, Sudan, Palestine and the broader Levant. We design JFDA dossiers as regional anchor references where the commercial plan supports onward filings.
What cold-chain routes do you use into Jordan?
BOM-AMM via Dubai (Emirates), Doha (Qatar Airways) or Abu Dhabi (Etihad), with Envirotainer or va-Q-tec containers and continuous temperature logging. Aqaba Port for ambient sea-freight volume with four-hour road haulage to Amman. Insurance on Institute Cargo Clauses A, door-to-door.
How is payment typically structured with Jordanian importers?
First-time: TT 30% advance, 70% against scanned Bill of Lading, or a sight LC through Arab Bank, Housing Bank, Jordan Kuwait Bank or HSBC Jordan. Repeat customers, post five clean shipments, move to open account at 60 to 90 days subject to credit-insurer cover.
Why buyers choose M Care for the India → Jordan corridor.
JFDA fluency
Dossiers built to the exact format JFDA reviews, not a generic CTD dump. We know which modules get scrutinised first, which stability data triggers queries, and which legalisation and apostille chain the submission needs to clear on the first pass.
Logistics you can schedule around
BOM → AMM direct air for time-critical orders, and Aqaba for high-volume ambient sea freight. Cold-chain SKUs run on validated containers with continuous temperature logging. Consolidation at origin so you order by molecule, not by MOQ.
Commercial discipline, one point of contact
USD invoicing with clear FX-clause language, LC / TT / open-account progression as the relationship proves out, 18 therapeutic areas on one PO, and one named account manager from enquiry through clearance in Jordan.
Top categories we ship to Jordan
Anti-infectives
Penicillins, cephalosporins, carbapenems, antivirals, antimalarials — 1,800+ hospital and retail lines.
Cardiovascular
Antihypertensives, statins, anticoagulants, antiarrhythmics and heart-failure lines.
Oncology
Cytotoxics, targeted therapy and supportive care — bortezomib, docetaxel, paclitaxel, gemcitabine.
Diabetes & endocrine
Insulins, oral antidiabetics, thyroid and hormonal therapy — 470+ lines across the spectrum.
CNS & neurology
Antiepileptics, antipsychotics, antidepressants, anxiolytics and neuroprotective lines.
General & OTC
Analgesics, vitamins, wound-care, nutritionals — 1,283 SKUs, our broadest catalogue.
Molecule, volume, target buyer. One working day to a quote.
Your enquiry goes directly to the account manager responsible for Jordan. No call-centre hops, no generic autoresponders, just the answer your procurement file needs.
Start a Jordan enquiry → Back to all markets